↓ Skip to main content

Adjuvant radiotherapy for stage I endometrial cancer

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
1 X user
wikipedia
15 Wikipedia pages

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
160 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adjuvant radiotherapy for stage I endometrial cancer
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd003916.pub4
Pubmed ID
Authors

Anthony Kong, Nick Johnson, Henry C Kitchener, Theresa A Lawrie

Abstract

This is an updated version of the original Cochrane review published in Issue 2, 2007. The role of radiotherapy (both pelvic external beam radiotherapy (EBRT) and vaginal intracavity brachytherapy (VBT)) in stage I endometrial cancer following hysterectomy remains controversial.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
United States 1 <1%
Germany 1 <1%
Unknown 157 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 19 12%
Researcher 15 9%
Student > Ph. D. Student 14 9%
Student > Master 13 8%
Student > Doctoral Student 11 7%
Other 35 22%
Unknown 53 33%
Readers by discipline Count As %
Medicine and Dentistry 74 46%
Biochemistry, Genetics and Molecular Biology 8 5%
Nursing and Health Professions 6 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Social Sciences 3 2%
Other 11 7%
Unknown 54 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 August 2022.
All research outputs
#4,857,628
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#6,973
of 11,499 outputs
Outputs of similar age
#30,573
of 174,458 outputs
Outputs of similar age from Cochrane database of systematic reviews
#98
of 177 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,458 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 177 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.